Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Assets (2016 - 2025)

Historic Assets for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Innoviva's Assets rose 1603.54% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1603.54%. This contributed to the annual value of $1.3 billion for FY2024, which is 462.83% up from last year.
  • Innoviva's Assets amounted to $1.4 billion in Q3 2025, which was up 1603.54% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Innoviva's Assets registered a high of $1.4 billion during Q3 2025, and its lowest value of $789.2 million during Q2 2021.
  • Moreover, its 5-year median value for Assets was $1.2 billion (2024), whereas its average is $1.2 billion.
  • In the last 5 years, Innoviva's Assets skyrocketed by 4964.54% in 2022 and then tumbled by 1051.49% in 2023.
  • Innoviva's Assets (Quarter) stood at $926.4 million in 2021, then soared by 32.93% to $1.2 billion in 2022, then rose by 0.98% to $1.2 billion in 2023, then rose by 4.63% to $1.3 billion in 2024, then increased by 9.84% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.